Steve Harr

Insider Reports History

Entity
Individual
Location
307 Westlake Ave. North, Ste. 300, Seattle, WA
Signature
/s/ Julie Shah, Attorney-in-Fact for Steve Harr
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve Harr:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. President & CEO, Director Restricted Stock Units 200K $1.1M $5.50 Mar 7, 2024 Direct
Sana Biotechnology, Inc. President & CEO, Director Stock Option (Right to Buy) 900K Mar 7, 2024 Direct

Insider Reports Filed by Steve Harr

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SANA Sana Biotechnology, Inc. Mar 7, 2024 2 $0 4 Mar 8, 2024 President & CEO, Director
SANA Sana Biotechnology, Inc. Mar 2, 2023 1 $0 4 Mar 3, 2023 President & CEO, Director
SANA Sana Biotechnology, Inc. Mar 3, 2022 1 $0 4 Mar 8, 2022 President & CEO, Director
SANA Sana Biotechnology, Inc. Apr 14, 2021 2 $0 4 Apr 15, 2022 President & CEO, Director